Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.
Surg Today
; 45(11): 1341-51, 2015 Nov.
Article
in En
| MEDLINE
| ID: mdl-25417186
ABSTRACT
In 2011, a new pathological classification of lung adenocarcinoma was proposed by the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society. The new criteria classify adenocarcinomas into eight subtypes according to their histological features. The criteria introduce a new concept of early stage lung cancer, consisting of adenocarcinoma in situ and minimally invasive adenocarcinoma, and categorize invasive adenocarcinomas by the predominant histological pattern. In addition to morphological differences among subtypes, the classification also considers the tumor behavior based on the genetic background within each subtype. We herein review the clinical impact of this new classification for chest surgeons based on the data from several recent validation studies from various institutions.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Thoracic Surgery
/
Adenocarcinoma
/
Surgeons
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2015
Type:
Article